SecBot SecBot
SECBOTREPLAY Home › Report › LYEL

LYEL · Two funds affiliated with ARCH Venture Partners collectively purchased…

Lyell Immunopharma, Inc. · CLUSTER filed Mar 5, 2026 at 19:00 ET

At the news

BULLISHIMPACT 8/10

CLUSTER filed Mar 5, 2026 at 19:00 ET

Two funds affiliated with ARCH Venture Partners collectively purchased nearly $25 million worth of Lyell Immunopharma shares in open-market transactions at $25.61 per share. This represents a significant, coordinated investment by a major biotech venture firm, signaling strong confidence in the company's future prospects.

  • ARCH Venture Partners IX, LLC purchased 488,090 shares at $25.61 for $12,500,000
  • ARCH Venture Fund XIII, L.P. purchased 488,090 shares at $25.61 for $12,500,000
  • Total open-market purchases: $25.0M across two affiliated funds
  • Transactions occurred on 2026-03-06 in a single day

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access